Literature DB >> 33993131

Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.

Jake A Ruddy1, Brian J Boyarsky, William A Werbel, Justin R Bailey, Andrew H Karaba, Jacqueline M Garonzik-Wang, Dorry L Segev, Christine M Durand.   

Abstract

In this study of 12 people with HIV who received the first dose of SARS-CoV-2 mRNA vaccination, anti-SARS-CoV-2 receptor binding domain antibodies were detectable in all participants; lower antibody levels were seen in those with lower CD4 counts, and vaccine reactions were generally mild.
Copyright © 2021 Wolters Kluwer Health, Inc.

Entities:  

Year:  2021        PMID： 33993131     DOI： 10.1097/QAD.0000000000002945

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  16 in total

1.  Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.

Authors:  Jane C Figueiredo; Fred R Hirsch; Lawrence H Kushi; Wendy N Nembhard; James M Crawford; Nicholas Mantis; Laurel Finster; Noah M Merin; Akil Merchant; Karen L Reckamp; Gil Y Melmed; Jonathan Braun; Dermot McGovern; Samir Parekh; Douglas A Corley; Namvar Zohoori; Benjamin C Amick; Ruofei Du; Peter K Gregersen; Betty Diamond; Emanuela Taioli; Carlos Sariol; Ana Espino; Daniela Weiskopf; Alba Gifoni; James Brien; William Hanege; Marc Lipsitch; David A Zidar; Ann Scheck McAlearney; Ania Wajnberg; Joshua LaBaer; E Yvonne Lewis; Raquel A Binder; Ann M Moormann; Catherine Forconi; Sarah Forrester; Jennifer Batista; John Schieffelin; Dongjoo Kim; Giulia Biancon; Jennifer VanOudenhove; Stephanie Halene; Rong Fan; Dan H Barouch; Galit Alter; Swetha Pinninti; Suresh B Boppana; Sunil K Pati; Misty Latting; Andrew H Karaba; John Roback; Rafick Sekaly; Andrew Neish; Ahnalee M Brincks; Douglas A Granger; Amy B Karger; Bharat Thyagarajan; Stefani N Thomas; Sabra L Klein; Andrea L Cox; Todd Lucas; Debra Furr-Holden; Kent Key; Nicole Jones; Jens Wrammerr; Mehul Suthar; Serre Yu Wong; Natalie M Bowman; Viviana Simon; Lynne D Richardson; Russell McBride; Florian Krammer; Meenakshi Rana; Joshua Kennedy; Karl Boehme; Craig Forrest; Steve W Granger; Christopher D Heaney; Maria Knight Lapinski; Shannon Wallet; Ralph S Baric; Luca Schifanella; Marcos Lopez; Soledad Fernández; Eben Kenah; Ashish R Panchal; William J Britt; Iñaki Sanz; Madhav Dhodapkar; Rafi Ahmed; Luther A Bartelt; Alena J Markmann; Jessica T Lin; Robert S Hagan; Matthew C Wolfgang; Jacek Skarbinski
Journal:  Open Forum Infect Dis       Date:  2022-04-27       Impact factor: 4.423

2.  Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV.

Authors:  Songjie Wu; Shi Zou; Fangzhao Ming; Mengmeng Wu; Wei Guo; Zhongyuan Xing; Zhiyue Zhang; Jinli Liu; Weiming Tang; Ke Liang
Journal:  Res Sq       Date:  2022-06-27

3.  A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.

Authors:  Megan A O'Connor; Jesse H Erasmus; Samantha Randall; Jacob Archer; Thomas B Lewis; Brieann Brown; Megan Fredericks; Skyler Groenier; Naoto Iwayama; Chul Ahrens; William Garrison; Solomon Wangari; Kathryn A Guerriero; Deborah H Fuller
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

Review 4.  Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.

Authors:  Yexin Yang; Akiko Iwasaki
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-29       Impact factor: 5.071

5.  Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV.

Authors:  Jessica J Tuan; Heidi Zapata; Terese Critch-Gilfillan; Linda Ryall; Barbara Turcotte; Suzana Mutic; Laurie Andrews; Michelle E Roh; Gerald Friedland; Lydia Barakat; Onyema Ogbuagu
Journal:  HIV Med       Date:  2021-10-10       Impact factor: 3.094

6.  Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data.

Authors:  Natalia A Díaz; Rosa de Miguel; Fernando Agüero; Omar Sued; José R Arribas; Juan Ambrosioni
Journal:  Infect Dis Ther       Date:  2021-10-28

7.  Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

Authors:  Zabrina L Brumme; Francis Mwimanzi; Hope R Lapointe; Peter K Cheung; Yurou Sang; Maggie C Duncan; Fatima Yaseen; Olga Agafitei; Siobhan Ennis; Kurtis Ng; Simran Basra; Li Yi Lim; Rebecca Kalikawe; Sarah Speckmaier; Nadia Moran-Garcia; Landon Young; Hesham Ali; Bruce Ganase; Gisele Umviligihozo; F Harrison Omondi; Kieran Atkinson; Hanwei Sudderuddin; Junine Toy; Paul Sereda; Laura Burns; Cecilia T Costiniuk; Curtis Cooper; Aslam H Anis; Victor Leung; Daniel Holmes; Mari L DeMarco; Janet Simons; Malcolm Hedgcock; Marc G Romney; Rolando Barrios; Silvia Guillemi; Chanson J Brumme; Ralph Pantophlet; Julio S G Montaner; Masahiro Niikura; Marianne Harris; Mark Hull; Mark A Brockman
Journal:  NPJ Vaccines       Date:  2022-02-28       Impact factor: 9.399

8.  Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients.

Authors:  Matthijs Oyaert; Marie-Angélique De Scheerder; Sophie Van Herrewege; Guy Laureys; Sofie Van Assche; Melissa Cambron; Leslie Naesens; Levi Hoste; Karlien Claes; Filomeen Haerynck; Tessa Kerre; Steven Van Laecke; Wim Van Biesen; Peggy Jacques; Bruno Verhasselt; Elizaveta Padalko
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

9.  Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals.

Authors:  Vera Portillo; Chiara Fedeli; Pilar Ustero Alonso; Ianis Petignat; Ellen Cristina Mereles Costa; Adi Sulstarova; Cyril Jaksic; Sabine Yerly; Alexandra Calmy
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

10.  Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.

Authors:  Lucas C Netto; Karim Y Ibrahim; Camila M Picone; Ana Paula P S Alves; Eliane V Aniceto; Mariana R Santiago; Patrícia S S Parmejani; Nadia E Aikawa; Ana C Medeiros-Ribeiro; Sandra G Pasoto; Emily F N Yuki; Carla G S Saad; Tatiana Pedrosa; Amanda N Lara; Carina Ceneviva; Eloisa Bonfa; Esper G Kallas; Vivian I Avelino-Silva
Journal:  Lancet HIV       Date:  2022-03-23       Impact factor: 16.070
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.